Vaccine-associated reduction in symptom severity among patients with influenza A/H3N2 disease
- 1 December 2015
- Vol. 33 (51) , 7160-7167
Abstract
No abstract availableKeywords
Funding Information
- Uniformed Services University of the Health Sciences
- National Institute of Allergy and Infectious Diseases
- National Institutes of Health (NIH)
This publication has 24 references indexed in Scilit:
- Influenza Illness and Hospitalizations Averted by Influenza Vaccination in the United States, 2005–2011PLOS ONE, 2013
- Development and Validation of the Influenza Intensity and Impact Questionnaire (FluiiQ™)Value in Health, 2011
- Safety, efficacy, and immunogenicity of an inactivated influenza vaccine in healthy adults: a randomized, placebo-controlled trial over two influenza seasonsBMC Infectious Diseases, 2010
- Comparative Efficacy of Inactivated and Live Attenuated Influenza VaccinesNew England Journal of Medicine, 2009
- Influenza vaccine effectiveness among 50–64-year-old persons during a season of poor antigenic match between vaccine and circulating influenza virus strains: Colorado, United States, 2003–2004Vaccine, 2007
- The Effectiveness of the Varicella Vaccine in Clinical PracticeNew England Journal of Medicine, 2001
- Inhaled Zanamivir for the Prevention of Influenza in FamiliesNew England Journal of Medicine, 2000
- Local and systemic cytokine responses during experimental human influenza A virus infection. Relation to symptom formation and host defense.Journal of Clinical Investigation, 1998
- APACHE—acute physiology and chronic health evaluation: a physiologically based classification systemCritical Care Medicine, 1981
- Altered reactivity to measles virus. Atypical measles in children previously immunized with inactivated measles virus vaccinesJAMA, 1967